Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery

Area of Science:

• Biotechnology
• Materials Science
• Oncology

Background:

• Amphiphilic block copolymer micelles improve chemotherapy drug delivery.
• Cell-penetrating peptides enhance micelle targeting and cellular uptake.
• Polyethylene glycol-polylactic acid (PEG-PLA) micelles are effective drug carriers.

Purpose of the Study:

• To synthesize and evaluate TAT-conjugated PEG-PLA nanoparticles for paclitaxel delivery.
• To assess the in vitro cytotoxicity and in vivo antitumor efficacy of TAT-conjugated nanoparticles.
• To identify limitations and suggest future modifications for improved cancer therapy.

Main Methods:

• Synthesis of maleimide-functionalized PEG-PLA block copolymers.
• Conjugation of transactivating transcriptional activator (TAT) peptide to PEG-PLA.
• Self-assembly of paclitaxel-loaded, TAT-conjugated nanoparticles (TAT-NP-PTX).
• In vitro cytotoxicity assays using MCF-7 breast cancer cells.
• In vivo pharmacokinetic and antitumor studies in a mice model.

Main Results:

• TAT-NP-PTX nanoparticles were successfully synthesized with a size of 20 nm.
• Enhanced in vitro cytotoxicity and cellular accumulation in MCF-7 cells.
• Accelerated plasma clearance and reduced in vivo antitumor activity of TAT-NP-PTX compared to non-conjugated nanoparticles.
• Positive charge of TAT peptide led to rapid elimination and toxicity in normal cells.

Conclusions:

• TAT conjugation enhances nanoparticle delivery and efficacy in vitro.
• In vivo limitations include rapid clearance and off-target toxicity due to positive charge.
• Shielding the positive charge of TAT peptide is crucial for improving in vivo performance.